Two weeks after vaccination with a granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting pancreatic tumor vaccine (GVAX), intratumoral TLOs with an active cellular and humoral immune response were induced (81). This evidence concerns the gene CSF2 and pancreatic neoplasm.